Clinical Outcome Assessments Toolbox for Radiopharmaceuticals

Developing Personalized Clinical Outcome Assessments

In recent years, patients, advocates, researchers, regulators, and other stakeholders have highlighted the importance of engaging patients more directly in medical product development and the regulatory review process. A key focus of these efforts has been advancing the science of patient input: identifying rigorous, systematic approaches to incorporating patient perspectives in medical product...

Electromembrane Processes, a Toolbox for Advanced Separations

Outcome measures for oral health based on clinical assessments and claims data: feasibility evaluation in practice

BACKGROUND It is well known that treatment variation exists in oral healthcare, but the consequences for oral health are unknown as the development of outcome measures is still in its infancy. The aim of this study was to identify and develop outcome measures for oral health and explore their performance using health insurance claims records and clinical data from general dental practices. ME...

Radiopharmaceuticals for Molecular Imaging

Radiopharmaceuticals for molecular imaging involve careful consideration of the following two factors: radionuclide selection and specificity to the molecular target. In selecting a radionuclide, the specific decay mode, physical half-life, chemical properties, and method of production must be considered. For proper design of a radiopharmaceutical which targets a specific biological or disease ...

Behavioral Assessments for Pre-Clinical Pharmacovigilance

Want to try a fun social experiment? Mention the term behavioral research to any scientist and watch their reaction. Some fi nd the idea of behavioral research daunting, while others think the fi eld isn’t really a science, just the mere act of watching a subject’s performance while making a few checkmarks on a clipboard. For those that have run behavioral experiments, we understand the theory ...